Home
Storia in 1 fonti
Swiss pharma faces potential US trade investigation as Washington turns up pressure on drug pricing
Interpharma warns Switzerland may face a US Section 301 trade probe targeting drug pricing, threatening $35.5 billion in pharma exports from Roche and
Raccontata da
cryptobriefing.com
Timeline cronologica
- ·
Swiss pharmaceutical industry faces potential US trade investigation
The US may open a trade investigation into Switzerland's pharmaceutical industry, threatening tariffs on $35.5 billion in imports and pressuring Roche and
- ·
Swiss pharma faces potential US trade investigation as Washington turns up pressure on drug pricing
Interpharma warns Switzerland may face a US Section 301 trade probe targeting drug pricing, threatening $35.5 billion in pharma exports from Roche and